Home/Filings/4/0000310764-24-000118
4//SEC Filing

Lobo Kevin 4

Accession 0000310764-24-000118

CIK 0000310764other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:20 PM ET

Size

14.8 KB

Accession

0000310764-24-000118

Insider Transaction Report

Form 4
Period: 2024-11-07
Lobo Kevin
Group Pres., Neurotech & Spine
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-07$93.06/sh+156,890$14,600,183256,917 total
  • Sale

    Common Stock

    2024-11-07$367.95/sh18,269$6,722,079139,071 total
  • Tax Payment

    Common Stock

    2024-11-07$369.02/sh99,577$36,745,905157,340 total
  • Sale

    Common Stock

    2024-11-07$368.58/sh23,178$8,542,947115,893 total
  • Sale

    Common Stock

    2024-11-07$369.75/sh15,866$5,866,454100,027 total
  • Exercise/Conversion

    Employee Stock Option granted 2/11/2015 (right to buy)

    2024-11-07156,8900 total
    Exercise: $93.06Exp: 2025-02-10Common Stock (156,890 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    695
Footnotes (5)
  • [F1]Includes 2,685 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2024, the date of the latest available statement of the reporting person's ESPP holdings.
  • [F2]The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.38 to $368.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  • [F3]The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.21 to $369.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  • [F4]The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.27 to $370.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
  • [F5]Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Issuer

STRYKER CORP

CIK 0000310764

Entity typeother

Related Parties

1
  • filerCIK 0001519419

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:20 PM ET
Size
14.8 KB